The Prescription: 17th April 2018 Issue
Editor’s EmulsionPSM INDIA Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSM Pill DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
News Archive

Pooja Khaitan

Warm Greetings!

Throughout the time we've seen print ads or watched TV commercials, there have been quite a few memorable ones that have captured the viewers' imagination. Among the ads that did catch our eyes, some of them were seen as breaking moral norms and were pushing the envelope a bit too far.
Advertising is seen as misleading if it involves false, misleading or deceptive information that is likely to cause the average consumer to act in a way they might otherwise not. Advertising may also be considered misleading if important information that the average consumer needs to make an informed decision is left out. According to data, one-third of complaints received against misleading ads come in from the healthcare sector. Read what our founder-director, Mr.Bejon Misra has to say on this apart from other details on this issue under PSM India Capsules.

The updated list of approved new drugs is available in the Drug Dopes section of this newsletter along with news on fake drugs being caught and sold in the markets of Karnataka, Bihar, Delhi and other parts of India. Read More>>>

Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on

Stay Healthy. Stay Protected.

Pooja Khaitan

The Prescription


“The National Health Protection Scheme(NHPS) is a very big step towards attaining universal healthcare coverage,"

Dr. Shamika Ravi, member of the Economic Advisory Council to Prime Minister of India

PSM India Capsules

Most Misleading Product Advertisements From Health Sector

About one-third of the complaints received against misleading advertisements are from the healthcare industry, suggests data from the Ministry Of Consumer Affairs. Data suggests as many as 6,820 complaints were recorded at Ministry’s ‘Grievance Against Misleading Advertisements” portal from March 2015 and March 2018. An official of the Ministry said that a maximum number of complaints is from the health sector.

Read More
Drug Laws & Policy Injections
Health Ministry Urges States To Adopt Clinical Establishment ActNew Delhi, 8 Apr 2018: The Union Health Ministry has urged states to adopt the Clinical Establishment Act, which aims to streamline healthcare services in India, stating they are the "most important partners" in rolling out of the free health insurance scheme that offers cover for 10 crore poor families.Read More
Parliamentary Committee Seeks Creation Of Separate Drug Controller For AYUSH Medicines New Delhi, 5 April 2018: A parliamentary committee today sought creation of a separate drug controller for AYUSH medicines and drugs in a time-bound manner to ensure they are on a par with international standards. The committee, which pointed out that market of Indian herbal drugs was declining worldwide, lamented the delay by the AYUSH ministry in fulfilling the assurance given on the issues of separate drug controller and legislations for education and practice of AYUSH systems of medicine.Read More
Government Bans Antibody Rapid Diagnostic Test Kits For MalariaNew Delhi, 4 APRIL 2018: Malaria antibody detection is performed using the indirect fluorescent antibody test for a patient who is infected with plasmodium and because of the time required for development of antibody and also the persistence of antibodies, serologic testing is not practical for routine diagnosis of acute malaria. Read More
CTRI's New Norm Of 'Registration Of Clinical Trials Only Prospectively' Comes Into EffectMumbai, 2 April 2018: The Clinical Trials Registry of India (CTRI)'s new rule of registration of clinical trials only prospectively has come into effect from April 1, 2018. The new rule practically means that registration of clinical trials/studies will be done before the enrollment of the first patient. Till now, CTRI accepts and registers trials which are ongoing and completed. Read More
India To Overhaul Drug Price Control SystemNew Delhi, 5 April 2018: The government is planning to overhaul the existing system of fixing drug prices in the country. The matter was to be discussed at a meeting on 10 April at the Prime Minister’s Office (PMO) with experts from central government think tank NITI Aayog, the department of pharmaceuticals, the National Pharmaceuticals Pricing Authority (NPPA) and the health ministry, two people aware of the matter said, requesting anonymity. Read More
No Proposal For A New Drug Policy At PresentNew Delhi, 3 April 2018: There is no definite proposal for a new drug policy before the government at present though some stakeholders have discussed the basic contents that should go into a draft pharma policy. This was in reply to a question raised in the parliament whether the government is proposing to formulate a new drug policy. Read More
Pharma Injections
Drugs Sold Without Regulator's Nod, Safety StudiesNew Delhi, 5 April 2018: In a shocking case which has come to light of the Union health ministry, domestic companies have been manufacturing and marketing 'harmful' medicines, without conducting studies to establish their safety and efficacy, and without approval of the national drug regulator. To make matters worse, some of these drugs are not even approved globally, but are being manufactured in India, putting patients at risk.Read More
Pharmacy Body To Crack Whip On Unregistered Persons Running Drug StoreBengaluru, 2 April 2018: To crack the whip on the misuse of registration and certification of a registered pharmacist, the Karnataka State Pharmacy Council has decided to appoint pharmacy inspectors. These inspectors will check whether the person running the drug store is registered or not.Read More
Pharma May See Recovery With FY19 Profit Set To Jump 20-22% New Delhi, 3 April 2018: After a bruising two years, the domestic pharmaceutical sector is set for a sharp turnaround in the new fiscal year with a 20-22 per cent growth in operating profit - the fastest pace since 2014, while revenue may grow at 9-11 per cent, according to a report. Read More
Olive Healthcare Faces Legal Action Over Violations New Delhi, 4 April 2018: Drug regulators across Monday and Tuesday raided the Daman factory of Olive Healthcare Ltd and seized drugs not approved for manufacture, two people aware of the development said. The Central Drugs Standard Control Organization (CDSCO) may initiate legal action against Olive Healthcare for various violations, the people cited above said. Read More
Drug Regulator Plans National Digital Database Of Pharma Manufacturers NEW DELHI, 2 APRIL 2018: India's drug regulatory body is creating a national digital database of pharmaceutical manufacturers and their medicines so that regulators can be more effective when acting on problems like drug shortages and quality issues, people aware of the development told ET. Read More
CCI Issues Advisory To Pharmaceutical Companies While Penalising All Kerala Chemists & Druggists Association New Delhi, 29 March 2018: By way of an October 31 2017 order, the Competition Commission of India (CCI) imposed monetary penalties on the All Kerala Chemists & Druggists Association (AKCDA) and two of its district units, as well as their office bearers, for ordering pharmaceutical companies to obtain no objection notices (NOCs) before appointing new stockists. Read More
Drug Dopes
Updated LIST OF NEW DRUGS APPROVED FROM 01-01-2018 TILL DATE BY NEW DRUGS DIVISION, CDSCO, FDA Bhawan, New Delhi List of New Drug Approved by FDA Read More
Schedule 'H' Drug Tramadol Being Sold Without Prescription In PunjabMohali, 7 April 2018: Despite strict central regulations, tramadol, a painkiller, continues to find its way into Punjab. Though the local pharmaceutical Industry has limited the manufacturing of this opioid-based drug, it is being supplied from other states and is available over-the-counter at most drug stores across the state. Read More
Fake Drug Raid Bares Decade-Old OperationPatna, 7 April 2018: The fake drug racket operating from a rented accommodation in Ashok Nagar, which drug inspectors unearthed on Thursday, was active since 2008, officials said. Officials found that Sanjay Kumar from Nawada, who is considered the kingpin of the racket, started the business after shifting his family to the first floor of the building. Read More
Karnataka DC Dept Seizes Sale Of Oxytocin Without License From Dairy Farmer At Belagavi Bengaluru, 9 April 2018: Even as the Union health ministry is weighing options for prohibiting the import of oxytocin and its formulations for human as well as animal use under section 10A of the D&C Act and regulating and restricting it under Section 26A of the Act, the Karnataka drugs control department has seized sale of oxytocin in Belgavi district of Karnataka for its misuse by a dairy farmer. Read More
Health Ministry Bans Over-The-Counter Sale Of 14 Steroid Creams NEW DELHI, 8 APRIL 2018: The government has banned over the counter sale of 14 skin creams and ointments containing steroids that were being extensively marketed for skin conditions like pigmentation, itching, and inflammation. Read More
Fake Drugs Recovered In Raid At Shop Patna, 6 April 2018: A huge quantity of fake drugs worth around Rs 25 lakh was recovered by the state drug control administration on Thursday. The recovery of fake drugs of well-known pharmaceutical companies, including Abbott Healthcare Private Limited, Alkem Laboratories Limited, Dr Reddy's Laboratories, Candid Pharmaceuticals and others from a rented accommodation of Ashok Nagar has surprised the drug inspectors. Read More
National Injections
Government’s Mini Drug Testing Lab Project Commissions New HPLC Machines, Recruits Staff To Enhance Surveillance Mumbai, 9 April 2018: The Union health ministry's mini drug testing lab project is fast catching up its pace with the appointment of staff and commissioning of new HPLC machines meant to assess drug purity and strength. The project envisages setting up of mini drug testing labs at Mumbai, Ahmedabad, Kolkata, Hyderabad, Bengaluru, Delhi and Chennai. Read More
RK Vats To Be New NPPA ChairmanNew Delhi, 7 April 2018: The Union government appointed Rakesh Kumar Vats as the chairman of the National Pharmaceutical Pricing Authority (NPPA) with immediate effect. The chairmanship of the Indian drug price regulator will be an additional charge for Vats, who is the additional secretary in the Ministry of Health and Family Welfare. Vats belongs to the 1986 West Bengal Indian Administrative Services (IAS) cadre.Read More
MBlood: Find A Donor Anytime Anywhere Mumbai, 2 April 2018: MBlood Donor app puts the power to save lives in the palm of your hand. Now, donating blood and platelets is easier than ever. MBlood helps users to send a request for the required blood group at any time, for any location where the blood is required. The user can also mention specific timing when the hospital can accept blood. On sending a request, all users registered with Mblood, based on the location, receive a notification of the requirement of blood. Any user interested in donating will post a reply via this mobile app. Read More
20 Specialists Found To Have Fake Degrees, 80 More Under Scanner MUMBAI, 6 APRIL 2018: The licences of 20 specialists in the medical profession in the state, including surgeons, paediatricians, radiologists and gynaecologists, have been suspended for fraudulently obtaining post-graduation degrees by paying an amount of Rs5-10 lakh. Eighty more specialists, feared to have been actively treating patients for five to seven years at private hospitals, are also being investigated. Read More
CAG Raps FDA Over Poor Functioning Of Drug Control Labs Mumbai, 5 April 2018: “Food and Drug Administration (FDA) working under the Medical Education and Drugs Department (MEDD) in Maharashtra have failed in ensuring the quality of drugs supplied due to inadequate testing and failure to follow-up effectively. This can have serious consequences for the health and welfare of the public,” slams Comptroller and Auditor General of India (CAG) in its recent report. Read More
Global Injections
Research Team Identifies New Class Of Antibiotics To Fight Drug Resistance Chikago, 6 April 2018: Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics. Read More
Governments Urged To Tackle Scourge Of Fake Drugs London, 29 March 2018: Governments are being urged to crack down on the trade in fake and shoddy drugs which is thought to be killing hundreds of thousands of people every year. Read More

US FDA Working On A 'Dozen' Policies To Boost Copycat Biotech Drugs NEW YORK, 28 MARCH 2018 (Reuters) - The U.S. Food & Drug Administration is working on around a dozen actions to boost use of cheaper versions of expensive biotech medicines, the head of the agency Scott Gottlieb said on Wednesday.Read More

Researchers Develop Unique Technology To Overcome Global Antibiotic Resistance Crisis England, 23 March 2018: Researchers from AGA Nanotech ltd, working with University College London (UCL), have developed a unique alternative to antibiotics.Read More


Want To Meet The Original DEA Agents From Netflix’s NARCOS?

April 9, 2018 : This event is going to be popular – register to secure your seat. Priority will be given to registered congressional staff. Former DEA Agents Who Inspired Netflix Series “Narcos” Join Policymakers to Discuss Latest Threats Posed By Illegally-Imported Fentanyl

Read More

Kingpin Responsible For Smuggling Mass Quantities Of Fentanyl Into NYC Charged

April 6, 2018: NBC4 New York reported that charges were filed in state court against an alleged drug kingpin that authorities say flooded the streets of New York City with enough fentanyl to kill approximately 10 million people. Francisco Quiroz-Zamora pleaded not guilty to one count of operating as a major trafficker, one count conspiracy in the second degree, and two counts criminal sale of a controlled substance. He is being held without bail.

Read More

Frequently Asked Questions Universal Health Coverage
Q1: How can we measure universal health coverage?
As universal health coverage is a combination of whether people obtain the health services they need and financial risk protection, measurement needs to include both components. Coverage of health services can be measured by the percentage of people receiving the services they need: for example women in fertile age groups accessing modern methods of family planning or children immunized. On the other hand, financial risk protection can be evaluated by a reduction in the number of families pushed into poverty or placed under severe economic strain due to health costs. The impact of these steps on population health and household financial wellbeing can also be measured, as can many of the factors that make it easier to increase coverage. These include the availability of essential medicines, for example.
The main challenge is that many countries do not have the capacity to measure coverage of all of the many health interventions that their populations needs. So they will need to choose a set of key indicators to track performance in service coverage. A sub-set of these could be used to compare performance between countries.


Should Computer Simulations Replace Animal Testing for Heart Drugs?

Computational models representing human heart cells show higher accuracy than animal models in predicting an adverse drug effect, such as dangerous arrhythmias, Elisa Passini, Blanca Rodriguez, Patricia Benito, The Conversation US

March 27, 2018: Safety is imperative before new medicines are given to patients—which is why drugs are tested on millions of animals worldwide each year to detect possible risks and side effects. But research shows computer simulations of the heart have the potential to improve drug development for patients and reduce the need for animal testing. Read More

Upcoming Events
UpComing Events
Click Here For More Events
Laughter Dose
Blog Addicts
Dr. Pankaj, MD Medicine tweets Thanks to The Prescription for making my day interesting. Let’s keep reading for better health!
Prof. Anju Gupta saysIgnorance about fake drugs can claim lives like nothing else. So, it’s better to keep one-self updated with The Prescription!
Deepak Goel, academician blogs I wish all success to PSM India for its honest effort to make us aware of fake drugs menace and news on healthcare!
This Newsletter is brought to you by
© 2011 Partnership for Safe Medicines India
F-9, 2nd floor, Kailash Colony, New Delhi -110048;;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.UnSubscribe Link